期刊文献+

G9a特异性siRNA表达载体的构建及在QBC939细胞中对G9a基因表达的影响 被引量:1

Construction of G9a specific siRNA expressing vector and its influence on G9a expression in cholangiocarcinoma QBC939 cell lines
原文传递
导出
摘要 目的构建特异性组蛋白甲基转移酶G9a基因的siRNA表达载体并检测QBC939细胞对G9a表达的抑制作用。方法设计、合成G9a特异性的短链寡核苷酸,经退火形成双链DNA片段.克隆到pSilencer neo^TM2.1-U6载体中,构建G9a特异性siRNA的表达载体。EcoRⅠ+BamHⅠ和EcoRⅠ+HindⅢ双酶切及测序鉴定重组体,并转染QBC_(939)细胞,G418筛选出稳定表达细胞株,半定量RT-PCR方法和Western印迹法检测G9a mRNA和蛋白的表达水平。结果双酶切与测序鉴定证实成功构建了G9a-siRNA表达载体,转染人胆管癌细胞株QBC939后,在mRNA和蛋白表达水平对G9a的抑制率分别为55.2%和54.8%。结论运用pSileneer neo^TM2.1-U6载体构建的G9a-siRNA表达载体可有效抑制G9a在胆管癌细胞株QBC939中的表达。 Objective To construct histone methyhransferase Gga siRNA expressing vector and to exam its inhibiting effect on Gga expression in a cholangiocarcinoma QBC939 cell lines. Method G9a specific oligonucleotides were designed and synthesized. These oligonucleotides were annealed to form a double strand DNA fragments and this fragment was cloned into pSilencer neo^TM 2. 1-U6 vector. The recombinant Gga-siRNA expressing product was confirmed by using EcoR + BamH Ⅰ and EcoR + Hind Ⅲ double digestion and by sequencing. The Gga-siRNA was transfected into QBC939 cell and G418 was used for selecting stable cell line. The inhibitory effect of Gga-siRNA construct was examined with semiquantitative RT-PCR and Western blot. Result Gga-siRNA expression vector was successfully constructed, and it can effectively reduce the mRNA (55. 2% ) and protein (54, 8% ) levels of Gga in stable transfected QBC939. Conclusion The Gga-siRNA expression vector can effectively inhibit the expression of Gga in cholangiocarcinoma cell line QBC939.
出处 《中华普通外科杂志》 CSCD 北大核心 2007年第7期530-532,共3页 Chinese Journal of General Surgery
基金 国家高技术研究发展计划(863计划)资金资助项目(2002AA214061)
关键词 胆管肿瘤 基因 组蛋白甲基转移酶 G9a SIRNA Bile duct neoplasms Genes Histone methyltransferase G9a siRNA
  • 引文网络
  • 相关文献

参考文献7

  • 1Rea S,Eisenhaber F,O'Carroll D,et al.Regulation of chromatin structure by site-specifi hitone H3 methyltransferase.Nature,2000,406:593-599.
  • 2Rong W,Anna VT,Prim B,et al.Differential subnuclear localization and replication timing of histone H3 lysine 9methylation states.Mol Biol Cell,2005,16:2872-2881.
  • 3Xin Z,Tachibana M,Guggiari M,et al.Role of histone methyltransferase G9a in CpG methylation of the Prader-Willi syndrome imprinting center.J Biol Chem,2003,278:14996-15000.
  • 4Nishio H,Walsh MJ.CCAAT displacement protein/cut homolog rccruits G9a histone lysine methltransferase to repress transcription.Proc Natl Acad Sci USA,2004,101:11257-11262.
  • 5Wozniak RJ,Klimecki WT,Lau SS,et al.5-Aza-2'-dcoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3-K9 dimethylation levels are linked to tumor suppressor gene reactivation.Oncogene,2007,26:77-90.
  • 6陈勇军,唐启彬,邹声泉.散发性肝外胆管癌中RASSF1A基因启动子甲基化状态的研究[J].中华实验外科杂志,2004,21(12):1430-1432. 被引量:13
  • 7唐启彬,石雪涛,衣龙海,孙华文,邹声泉.肝外胆管癌中染色体9p21区段抑癌基因簇表达异常的研究[J].肿瘤防治研究,2004,31(9):523-525. 被引量:7

二级参考文献18

  • 1陈勇军,唐启彬,邹声泉.RASSF1基因在肝外胆管癌组织中转录表达及其临床意义的研究[J].中华肝胆外科杂志,2005,11(2):107-109. 被引量:14
  • 2[1]Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer[J]. Cancer Res, 1998,58(22) :5071-5074.
  • 3[2]Sasaki S, Kitagawa Y, Sekido Y, et al. Molecular processes of chromosome 9p21 deletions in human cancers[J]. Oncogene, 2003,22(24):3792-3798.
  • 4[3]Calero Moreno TM, Gustafsson G, Garwicz S, et al. Deletion of the Ink4-locus (the p16ink4a, P14arf and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92[J]. Leukemia, 2002,16(10):2037-2045.
  • 5[4]Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer[J]. Oncogene, 2002,21(45):6908-6914.
  • 6[5]Peng CY, Chen TC, Hung SP, et al. Genetic al terations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma[J]. Anticancer Res, 2002,22(2B) :1265-1271.
  • 7[6]Bazan V, Zanna I, Migliavacca M, et al. Prognostic significance of p16IN K4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma[J]. J Cell Physiol, 2002,192(3):286-293.
  • 8[7]Yoshida S, Todoroki T, Ichikawa Y, et al. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers[J]. Cancer Res, 1995,55(13):2756 -2760.
  • 9[8]Tannapfel A, Sommerer F, Benicke M, et al. Genetic and epigenetic alterat ions of the INK4a-ARF pathway in cholangiocarcinoma[J]. J Pathol, 2002,197(5) :624-631.
  • 10[9]Caca K, Feisthammel J, Klee K, et al. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines[J]. Int J Cancer, 2002,97(4):481-488.

共引文献15

同被引文献4

引证文献1

相关主题

;
使用帮助 返回顶部